VBM anticipates the rate of progression of Alzheimer disease: A 3-year longitudinal study

Neurology

Volumn 70, Issue 23, 2008, Pages 2201-2211

  Kinkingnehun S ^a,b,c   Sarazin, M ^a,d,g   Lehericy S ^a,b,d,e,f   Guichart Gomez, E ^d   Hergueta, T ^d   Dubois, B ^a,d,f  

^a INSERM   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c E(ye)BRAIN   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Center for NeuroImaging Research CENIR   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g Hospital de la Salpestriére   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTIONAL BATTERY OF THE CAMBRIDGE NEUROPSYCHOLOGICAL TESTS AUTOMATED BATTERY; BRAIN CORTEX ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CUNEUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LINGUAL GYRUS; LONGITUDINAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PARIETAL LOBE; PARIETOOCCIPITAL SULCUS; PRECUNEUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VOXEL BASED MORPHOMETRY; ATROPHY; COGNITION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; FOLLOW UP; MORTALITY; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; ATROPHY; COGNITION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS;

EID: 44949135105     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000303960.01039.43     Document Type: Article

References (41)

1. Adak S, Illouz K, Gorman W, et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology 2004;63:108-114.
2. Sarazin M, Horne N, Dubois B. Natural decline and prognostic factors. In: Alzheimer's Disease and Related Disorders, Third Edition. London: Dunitz, 2006: 135- 145.
3. Sarazin M, Stern Y, Berr C, et al. Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology 2005;64:1027-1031.
4. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain 1996;119: 2001-2007.
5. Jack CRJ, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
6. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002;72:491-497.
7. Du AT, Schuff N, Kramer JH, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 2004;62:422-427.
8. Jack CR Jr, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62: 591-600.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
10. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43: 2412-2414.
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
12. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987;37:1649-1653.
13. Benton A. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
14. Sano M, Devanand DP, Richards M, et al. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995; 52:961-966.
15. Stern Y, Albert M, Brandt J, et al. Utility of extrapyra-midal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 1994;44:2300-2307.
16. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology 1988;38:900-903.
17. Goldblum MC, Gomez CM, Dalla Barba G, et al. The influence of semantic and perceptual encoding on recognition memory in Alzheimer's disease. Neuropsychologia 1998;36:717-729.
18. Benton A. The Revised Visual Retention Test, 4th ed. New York: Psychological Corporation,1974.
19. Sirigu A, Cohen L, Duhamel JR, Pillon B, Dubois B, Agid Y. A selective impairment of hand posture for object utilization in apraxia. Cortex 1995;31:41-55.
20. Rosen W. Neuropsychological Investigation of Memory, Visuoconstructional, Visuoperceptual, and Language Abilities in Senile Dementia of the Alzheimer Type. New York: Raven Press,1983.
21. Deloche G, Hannequin D. Test de dénomination orale d'images DO 80. Les Editions du Centre de Psychologie Appliquée ed. Paris, France: Les Editions du Centre de Psychologie Appliquée, 1997.
22. Kaplan E, Goodglass H, Weinstraub S. The Boston Naming Test, 2nd ed. Philadelphia: Lea and Febiger, 1983.
23. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-1626.
24. Robbins TW, James M, Owen AM, et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc 1998;4:474-490.
25. Dorion AA, Sarazin M, Hasboun D, et al. Relationship between attentional performance and corpus callosum morphometry in patients with Alzheimer's disease. Neuropsychologia 2002;40:946-956.
26. Ballard C, O'Brien J, Morris CM, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:499-503.
27. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11 (6 Pt 1):805-821.
28. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14 (1 Pt 1):21-36.
29. Senjem ML, Gunter JL, Shiung MM, Petersen RC, Jack CR Jr. Comparison of different methodological implementations of voxel-based morphometry in neurode-generative disease. Neuroimage 2005;26:600-608.
30. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme, 1988.
31. Chételat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. NeuroImage 2005;27:934-946.
32. Worsley KJ, Andermann M, Koulis T, MacDonald D, Evans AC. Detecting changes in nonisotropic images. Hum Brain Mapp 1999;8:98-101.
33. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004;22: 676-687.
34. Moorhead TW, Job DE, Spencer MD, Whalley HC, Johnstone EC, Lawrie SM. Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia. Neuroimage 2005;28:544-552.
35. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15:273-289.
36. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000;21:19-26.
37. Delacourte A, David JP, Sergeant N, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999;52:1158-1165.
38. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann NY Acad Sci 2000;924:53-61.
39. Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
40. Johannsen P, Jakobsen J, Bruhn P, Gjedde A. Cortical responses to sustained and divided attention in Alzheimer's disease. Neuroimage 1999;10 (3 Pt 1):269-281.
41. Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005;382:269-274.